3D-QSAR investigation of the tripos benchmark steroids and some protein-tyrosine kinase inhibitors of styrene type using the TDQ approach

Protein Tyrosine Kinase ◽

Kinase Inhibitors ◽

3D Qsar ◽

Protein Tyrosine Kinase Inhibitors Promote Amylase Secretion and Inhibit Ornithine Decarboxylase Induction in Sialagogue-Stimulated Rat Parotid Explants

Biochemical and Biophysical Research Communications ◽

10.1006/bbrc.1996.0864 ◽

1996 ◽

Vol 223 (1) ◽

pp. 170-174 ◽

Cited By ~ 1

Author(s):

Fumiyo Kinoshita ◽

Akemichi Ueno ◽

Yoshihiro Miwa ◽

Mizuho Nishino ◽

Hideo Inoue

Keyword(s):

Tyrosine Kinase ◽

Ornithine Decarboxylase ◽

Protein Tyrosine Kinase ◽

Kinase Inhibitors ◽

Amylase Secretion ◽

Protein Tyrosine ◽

Rat Parotid

Strategies toward the Design of Novel and Selective Protein Tyrosine Kinase Inhibitors

Pharmacology & Therapeutics ◽

10.1016/s0163-7258(98)00044-8 ◽

1999 ◽

Vol 82 (2-3) ◽

pp. 195-206 ◽

Cited By ~ 244

Author(s):

Peter Traxler ◽

Pascal Furet

Keyword(s):

Tyrosine Kinase ◽

Protein Tyrosine Kinase ◽

Kinase Inhibitors ◽

Opposing effects of protein tyrosine kinase inhibitors on the monoclonal antibody induced internalization of CD3 and CD4 antigens

European Journal of Immunology ◽

10.1002/eji.1830211052 ◽

1991 ◽

Vol 21 (10) ◽

pp. 2641-2643 ◽

Cited By ~ 6

Author(s):

Laure Thuillier ◽

Jean-Louis Pérignon ◽

Françoise Selz ◽

Claude Griscelli ◽

Alain Fischer

Keyword(s):

Monoclonal Antibody ◽

Tyrosine Kinase ◽

Protein Tyrosine Kinase ◽

Kinase Inhibitors ◽

Protein Tyrosine ◽

Opposing Effects

Synthesis and evaluation of new protein-tyrosine kinase inhibitors. Part 1. pyridine-containing stilbenes and amides.

Bioorganic & Medicinal Chemistry Letters ◽

10.1016/s0960-894x(00)80254-1 ◽

1991 ◽

Vol 1 (4) ◽

pp. 211-214 ◽

Cited By ~ 7

Author(s):

Mark Cushman ◽

Dhanapalan Nagarathnam ◽

D. Gopal ◽

Robert L. Geahlen

Keyword(s):

Tyrosine Kinase ◽

Protein Tyrosine Kinase ◽

Kinase Inhibitors ◽

Protein Tyrosine ◽

New Protein

6 Protein Tyrosine Kinase Inhibitors

Progress in Medicinal Chemistry ◽

10.1016/s0079-6468(08)70307-2 ◽

1996 ◽

pp. 233-329 ◽

Cited By ~ 20

Author(s):

Paul W. Groundwater ◽

Kevin R.H. Solomons ◽

Jacqueline A. Drewe ◽

Munawar Ali Munawar

Keyword(s):

Tyrosine Kinase ◽

Protein Tyrosine Kinase ◽

Kinase Inhibitors ◽

The role of small molecule Kit protein-tyrosine kinase inhibitors in the treatment of neoplastic disorders

Pharmacological Research ◽

10.1016/j.phrs.2018.04.020 ◽

2018 ◽

Vol 133 ◽

pp. 35-52 ◽

Cited By ~ 28

Author(s):

Robert Roskoski

Keyword(s):

Tyrosine Kinase ◽

Small Molecule ◽

Protein Tyrosine Kinase ◽

Kinase Inhibitors ◽

Protein Tyrosine ◽

Neoplastic Disorders

Protein-Tyrosine Kinase Inhibitors

Encyclopedia of Cancer ◽

10.1007/978-3-662-46875-3_101903 ◽

2016 ◽

pp. 3832-3832

Keyword(s):

Tyrosine Kinase ◽

Protein Tyrosine Kinase ◽

Kinase Inhibitors ◽

Protein tyrosine kinase inhibitors

Reactions Weekly ◽

10.1007/s40278-019-70544-y ◽

2019 ◽

Vol 1776 (1) ◽

pp. 386-386

Keyword(s):

Tyrosine Kinase ◽

Protein Tyrosine Kinase ◽

Kinase Inhibitors ◽

Effects of Protein Tyrosine Kinase Inhibitors with Different Modes of Action on Topoisomerase Activity and Death of IL-2-Dependent CTLL-2 Cells1

The Journal of Biochemistry ◽

10.1093/oxfordjournals.jbchem.a124908 ◽

1995 ◽

Vol 118 (2) ◽

pp. 312-318 ◽

Cited By ~ 23

Author(s):

Yutaro Azuma ◽

Yoshiaki Onishi ◽

Yutaka Sato ◽

Harutoshi Kizaki

Keyword(s):

Tyrosine Kinase ◽

Protein Tyrosine Kinase ◽

Kinase Inhibitors ◽

Protein Tyrosine ◽

Modes Of Action

Current evidence on thyroid related adverse events in patients treated with protein tyrosine kinase inhibitors

Drug Metabolism Reviews ◽

10.1080/03602532.2019.1687512 ◽

2019 ◽

Vol 51 (4) ◽

pp. 562-569

Author(s):

Katalin Gabora ◽

Andra Piciu ◽

Iulian Claudiu Bădulescu ◽

Maria Iulia Larg ◽

Ioan-Adrian Stoian ◽

...

Keyword(s):

Adverse Events ◽

Tyrosine Kinase ◽

Protein Tyrosine Kinase ◽

Kinase Inhibitors ◽

Current Evidence ◽